SEARCH RESULTS FOR: "Tag: BIIB"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2022(5)
2021(7)
2020(4)
2019(15)
2018(7)
2017(14)
2016(14)
2015(15)
2014(1)
CATEGORIES
5-Minute Market Rundown(4)
Analyst Update(12)
Analyst Upgrades(3)
Buzz Stocks(30)
By the Numbers(2)
Earnings Preview(3)
Ezines(2)
General(5)
Intraday Option Activity(12)
Market Recap(1)
Midday Market Check(5)
Opening View(7)
Quantitative Analysis(2)
Stock Market News(4)
Stocks On the Move(10)
Technical Analysis(1)
The Week Ahead(1)

9/28/2022 9:16 AM
The shares of Biogen Inc (NASDAQ:BIIB) are seeing an unprecedented surge ahead of the open, last seen up 53.2% at $302.91 after announcing that the experimental Alzheimer's drug it developed in conju...
7/20/2022 10:21 AM
Biogen Inc (NASDAQ: BIIB ) earlier lifted its full-year profit forecast after reporting blowout second-quarter profits of $5.25 per share on revenue of $2.59 billion, both of which came in above Wall...
5/3/2022 10:16 AM
Biogen Inc (NASDAQ:BIIB) stepped into the earnings confessional today to post first-quarter earnings of $3.62 per share -- lower than the $4.38 per share analysts anticipated -- due to Alzheimer's dr...
3/24/2022 12:47 PM
Viatris Inc (NASDAQ:VTRS) is up 0.5% to trade at $10.94 at last check. Just last week, the company announced the U.S. Court of Appeals denied a request from Biogen (BIIB) to reconsider its decision af...
2/3/2022 10:36 AM
The shares of Biogen Inc (NASDAQ:BIIB) are down 5% to trade at $213.70 at last check, as the company's bleak 2022 forecast weighs. Biogen announced fourth-quarter earnings of $3.39 per share, which i...